Richard L. Gulino
2017
In 2017, Richard L. Gulino earned a total compensation of $1.8M as Senior Vice President, General Counsel and Secretary at Vanda Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $128,340 |
|---|---|
| Option Awards | $728,203 |
| Salary | $345,000 |
| Stock Awards | $565,500 |
| Other | $25,856 |
| Total | $1,792,899 |
Gulino received $728.2K in option awards, accounting for 41% of the total pay in 2017.
Gulino also received $128.3K in non-equity incentive plan, $345K in salary, $565.5K in stock awards and $25.9K in other compensation.
Rankings
In 2017, Richard L. Gulino's compensation ranked 6,047th out of 14,666 executives tracked by ExecPay. In other words, Gulino earned more than 58.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,047 out of 14,666 | 59th |
Division Manufacturing | 2,219 out of 5,768 | 62nd |
Major group Chemicals And Allied Products | 700 out of 2,074 | 66th |
Industry group Drugs | 539 out of 1,730 | 69th |
Industry Pharmaceutical Preparations | 424 out of 1,329 | 68th |
Source: SEC filing on April 27, 2018.
Gulino's colleagues
We found four more compensation records of executives who worked with Richard L. Gulino at Vanda Pharmaceuticals in 2017.
2017
Mihael Polymeropoulos
Vanda Pharmaceuticals
Chief Executive Officer
2017
James Kelly
Vanda Pharmaceuticals
Chief Financial Officer
2017
Gian Reverberi
Vanda Pharmaceuticals
Senior Vice President, Chief Commercial Officer
2017
Gunther Birznieks
Vanda Pharmaceuticals